AbbVie files reply in support of dismissing US antitrust case over Humira
MLex Summary: AbbVie filed a reply in support of its motion to dismiss US claims accusing it of entering into illegal agreements with pharmacy benefit managers to ensure that Humira would...To view the full article, register now.
Already a subscriber? Click here to view full article